Table 1. Structures, Biological Activity, and Properties of Pyrrole Compounds 1 and 7a–l.
compd | R | antiproliferationa IC50 (μM) | cellular microtubule lossb | binding mode | HINT scorec | HINT log P | ALOGPsd |
---|---|---|---|---|---|---|---|
colchicine | 0.016 ± 0.002 | 100% loss at 0.5 μM | 549 | 3.24 | 1.59 | ||
1 | ethyl | 0.036 ± 0.002e | 100% loss at 0.5 μM | I | 418 | 2.60 | 4.44 |
7a | methyl | 0.618 ± 0.07 | 50% loss at 5 μM | I | 524 | 2.06 | 3.87 |
7b | n-propyl | 0.067 ± 0.002 | 75% loss at 5 μM | I | 157 | 3.14 | 4.74 |
7c | i-propyl | 0.109 ± 0.008 | 70% loss at 5 μM | I | –179 | 3.14 | 4.70 |
7d | t-butyl | 1.82 ± 0.3 | no loss up to 10 μM | II | 187 | 3.24 | 5.02 |
7e | n-butyl | 1.30 ± 0.04 | 15% loss at 10 μM | II | 530 | 3.68 | 5.05 |
7f | n-hexyl | 3.3 ± 0.3 | 35% loss at 10 μM | II | 256 | 4.76 | 5.83 |
7g | benzyl | 5.3 ± 0.3 | no loss up to 10 μM | II | 713 | 3.61 | 5.39 |
7h | –(CH2)3NMe2 | 4.6 ± 0.2 | 10% loss at 10 μM | II | 293 | 2.52 | 4.10 |
7i | –(CH2)2NMe2 | 5.2 ± 0.3 | 10% loss at 10 μM | II | 358 | 2.57 | 3.82 |
7j | –(CH2)3NMe2H+Cl– | 8.0 ± 0.3 | no loss up to 10 μM | II | 631 | 0.27 | 0.39 |
7k | –(CH2)2NMe2H+Cl– | 10.7 ± 0.4 | no loss up to 10 μM | II | 774 | 0.78 | 0.27 |
7l | 4-methoxylphenyl | 18.3 ± 2.7 | no loss up to 10 μM | II | 957 | 4.37 | 5.48 |
Experiments were performed using human MDA-MB-435 cancer cells.
Loss of interphase microtubules was evaluated in A-10 cells.
515 HINT score units ≈ 1 kcal mol–1 (ref (15)).
ALOGPs were calculated at Virtual Computational Chemistry Laboratory, http://www.vcclab.org.
Ref (12).